Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Net Issuance of Debt
Meridian Bioscience Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Net Issuance of Debt
-$35m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Net Issuance of Debt
$92.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Net Issuance of Debt
-$59m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Net Issuance of Debt
-$601k
|
CAGR 3-Years
77%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Net Issuance of Debt?
Net Issuance of Debt
-35m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Net Issuance of Debt amounts to -35m USD.
What is Meridian Bioscience Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-56%
Over the last year, the Net Issuance of Debt growth was -297%.